Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5427]

NSCLC biology and new therapies: Reversing resistance

Prof Michael Seckl - Imperial College London, London, UK

NSCLC biology and new therapies: Reversing resistance ( Prof Michael Seckl - Imperial College London, London, UK )

NSCLC biology and new therapies: Immunotherapies

Dr Rafael Rosell - Catalan Institute of Oncology, Barcelona, Spain

NSCLC biology and new therapies: Immunotherapies ( Dr Rafael Rosell - Catalan Institute of Oncology, Barcelona, Spain )

Screening, surgical cure and new developments: Q & A

Dr Henschke, Prof Field, Dr Pastorino, Dr Di Meco

Screening, surgical cure and new developments: Q & A ( Dr Henschke, Prof Field, Dr Pastorino, Dr Di Meco )

Screening, surgical cure and new developments: Current state of the art surgery

Dr Ugo Pastorino - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Screening, surgical cure and new developments: Current state of the art surgery ( Dr Ugo Pastorino - Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy )

Tumour heterogeneity and the impact on patient care

Dr Nicholas McGranahan - The Francis Crick Institute, London, UK

Tumour heterogeneity and the impact on patient care ( Dr Nicholas McGranahan - The Francis Crick Institute, London, UK )

Immunotherapy in lung cancer: Q & A

Prof Giuseppe Giaccone and Dr Olivier Pardo

Immunotherapy in lung cancer: Q & A ( Prof Giuseppe Giaccone and Dr Olivier Pardo )

Immunotherapy in SCLC

Prof Dean Fennell - University of Leicester, Leicester, UK

Immunotherapy in SCLC ( Prof Dean Fennell - University of Leicester, Leicester, UK )

Immunotherapy in NSCLC

Prof Giuseppe Giaccone - Georgetown University, Washington DC, USA

Immunotherapy in NSCLC ( Prof Giuseppe Giaccone - Georgetown University, Washington DC, USA )

Omics, early detection and novel therapies: Q & A

Dr Murrell and Dr Pardo

Omics, early detection and novel therapies: Q & A ( Dr Murrell and Dr Pardo )

Omics, early detection and novel therapies: Metabolomics

Dr Olivier Pardo - Imperial College London, London, UK

Omics, early detection and novel therapies: Metabolomics ( Dr Olivier Pardo - Imperial College London, London, UK )

Small cell lung cancer: Q & A

Prof Gordon McVie, Prof Caroline Dive, Dr Fiona Blackhall and Dr Marianne...

Small cell lung cancer: Q & A ( Prof Gordon McVie, Prof Caroline Dive, Dr Fiona Blackhall and Dr Marianne Nicolson )

Small cell lung cancer: New therapies

Dr Fiona Blackhall - The Christie NHS Foundation Trust, Manchester, UK

Small cell lung cancer: New therapies ( Dr Fiona Blackhall - The Christie NHS Foundation Trust, Manchester, UK )

More from ecancer